Clinical controlled study on enhanced recovery after release manipulation for moderate to severe shoulder stiffness

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400083123

Enrollment

Unknown

Registered

2024-04-16

Start date

2024-05-01

Completion date

Unknown

Last updated

2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen shoulder

Interventions

Observation group :The upper brachial plexus trunk ultrasound-guided nerve block anesthesia under manual release, compound betamethasone injection (2% lidocaine 1mL+ compound betamethasone injection 1

Control group:Compound betamethasone injection, combined with shoulder exercise method and routine rehabilitation treatment

Eligibility

Sex/Gender

All

Age

40 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? It meets the diagnostic criteria of Western medicine for shoulder periarthritis and can be combined with non-full rotator cuff tear; ? Have X-ray and magnetic examination results, except for other shoulder diseases; ? Those who signed informed consent and voluntarily accepted treatment as subjects; ? After a washout period of more than 7 days if other treatments have been received.

Exclusion criteria

Exclusion criteria: ? Serious skin injury or skin disease at the treatment site; ? Allergic physique and allergic to a variety of drugs; ? Patients with serious life-threatening primary diseases such as cardiovascular and cerebrovascular, liver, kidney, hematopoietic system and endocrine system and mental illness; ? Patients with rheumatoid arthritis, joint tuberculosis, suppurative arthritis, allergic arthritis, thrombocytopenic purpura arthritis, dermatosis arthritis, Kaschinbeck disease, gout, intraarticular tumor and other specific joint diseases; ? Pregnant and lactating women. ? Patients with poor blood sugar control and HBA1c = 7%. ? Unwillingness to accept researchers. Subjects who are "no" in any of the above ? ~ 7 items are eligible to be enrolled in this clinical trial.

Design outcomes

Primary

Measure	Time frame
Constant-Murley score of shoulder joint;	—

Secondary

Measure	Time frame
VAS score;Ultrasonic evaluation;Shoulder joint range of motion score;	—

Countries

China

Contacts

Public ContactMa Jia

Wangjing Hospital of China Academy of Chinese Medical Sciences

f3c_ma@163.com+86 138 1122 7708

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 22, 2026